PSA和SPECT骨显像在前列腺癌诊断治疗中的意义  

Clinical Analysis of Combined Examination of Bone Scan and Serum PSA in the Diagnosis and Treatment of Prostate Carcinoma

作　　者：李斌[1] 张海滨[1] 廖黎黎[1] 

机构地区：[1]广东省佛山市第一人民医院泌尿外科,广东佛山528000

出　　处：《临床泌尿外科杂志》2011年第5期380-381,共2页Journal of Clinical Urology

摘　　要：目的:研究PSA、SPECT骨显像在前列腺癌诊断及治疗中的临床意义。方法:对100例经临床确诊的前列腺癌患者全部行血清PSA测定及全身骨显像。结果:发生骨转移的患者为81%.PSA≥20μg/L的患者发生骨转移的为60%。结论:血清PSA与骨显像联检对前列腺癌临床诊断、疗效观察及预后判定具有重要的指导意义。Objective：To analysis of the combined detection of radionuclide bone imaging and plasma levels of prostate specific antigen （PSA） in patients with prostate cancer. Methods： Measure the serum PSA level and conduct bone scan on all the 100 patients that had been diagnosed as prostatic cancer. Results： 81 percent of patients with prostate cancer had skeleton metastasis, when PSA ≥20μg /L , 60 percent of patients with prostate cancer had skeleton metastasis. Conclusions：The combined detection of radionuclide bone imaging and the serum PSA lev- els would play an important role in clinical diagriosis of bone metastases for patients with prostate cancer.

关 键 词：前列腺癌 骨转移 

分 类 号：R737.25[医药卫生—肿瘤]